Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DKS CoTSE:4461 +5.00%75 EBITDA Margin % is 18.00% as of Mar. 2026, which is 52% above its 10-year median of 11.81. GuruFocus rates TSE:4461 with a GF Score™ of 75/100 and a GF Value™ of 円4,161.39 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 1,578 Chemicals companies, DKS Co ranks better than 72.05% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. DKS Co's EBITDA for the
six
months ended in Mar. 2026 was 円8,149 Mil. DKS Co's Revenue for the
six
months ended in Mar. 2026 was 円45,275 Mil. Therefore, DKS Co's EBITDA margin for the quarter that ended in Mar. 2026 was 18.00%.
DKS Co (TSE:4461) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
DKS Co EBITDA Margin % Related Terms
DKS Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for DKS Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4461 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, DKS Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DKS Co EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DKS Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where DKS Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DKS Co (TSE:4461) has a EBITDA Margin % of 18.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DKS Co and its competitors. This is 52% above median its historical median of 11.81. Over the past decade, DKS Co's EBITDA Margin % has ranged from 6.10 to 16.16. According to the industry distribution chart, DKS Co ranks #441 out of 1578 companies in the Chemicals industry, placing it in the top 27.9%.
Is DKS Co's EBITDA Margin % too high?
DKS Co's current EBITDA Margin % of 18.00% is 52% above median its 10-year median of 11.81. Over the past 10 years, this metric has ranged from a low of 6.10 to a high of 16.16. The Chemicals industry median EBITDA Margin % is 9.64. DKS Co's value of 18.00% is 86.8% above this industry median. Based on the distribution chart, DKS Co ranks #441 out of 1578 companies in the Chemicals industry, which is above the industry midpoint. Overall, DKS Co has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DKS Co's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, DKS Co ranks #441 out of 1578 companies for EBITDA Margin %. This puts DKS Co in the upper half of its industry. The industry median EBITDA Margin % is 9.64. DKS Co's value of 18.00% is 86.8% above this benchmark. Historically, DKS Co's own EBITDA Margin % has ranged from 6.10 to 16.16 over the past decade. While the company's 10-year median is 11.81 vs. the industry median of 9.64, DKS Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DKS Co's current EBITDA Margin % of 18.00% is 86.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DKS Co and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DKS Co's current EBITDA Margin % is 18.00%, which is 52% above median its own 10-year median of 11.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DKS Co stock overvalued right now?
Based on GuruFocus' analysis, DKS Co (TSE:4461) is currently considered Significantly Overvalued. The stock's GF Value™ is 円4,161.39, compared to a current price of 円11,560.00 — trading 177.8% above its estimated fair value. The current EBITDA Margin % is 18.00%, which is 52% above median its 10-year median of 11.81 and 86.8% above the Chemicals industry median of 9.64. DKS Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For DKS Co (TSE:4461), the current EBITDA Margin % is 18.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DKS Co (TSE:4461) Overvalued in 2026?
Based on GuruFocus' analysis, DKS Co stock appears to be overvalued.
The current stock price of 円11,560.00 is trading 177.8% above its estimated GF Value™ of 円4,161.39.
GuruFocus considers DKS Co to be Significantly Overvalued.
Key valuation signals for TSE:4461:
EBITDA Margin %: 18.00% (52% above median its 10-year median of 11.81)
GF Value™: 円4,161.39 vs. price of 円11,560.00 (177.8% above fair value)
Industry Position: 86.8% above the Chemicals median (#441 of 1578)
No single metric tells the full story. See the TSE:4461 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4461 has been successfully added to your 
